The Big Marn' has opened up about being in the fight of his life since being diagnosed with non-Hodgkin lymphoma.

The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...

Claire Dougherty — a 22-year-old medical assistant from Philadelphia — loved going out with her friends and grabbing a drink. However, in August 2025, she started experiencing an unusual pain every ...

A $7.25 billion class action settlement meant to resolve claims that Monsanto’s Roundup products caused cancer in people has ...

Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

Ipsen found cases of secondary malignancies in a confirmatory study of Tavzerik, a medicine it got in a purchase of Epizyme ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

C.J. was diagnosed with Hodgkin's Lymphoma in June of last year. Donations raised from the dinner help C.J. with his medical bills and cancer treatment ...

Emma Operacz was feeling under the weather, and she initially believed she had a UTI. But a series of doctors and medical ...

She thought it was a case of the flu. As the weeks passed, the Pilates instructor's symptoms worsened. Weiss could no longer ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...